Blood test for early liver cancer warning in cirrhosis
Part of Cancer, Digestive system clinical trials.
This study looks at whether a blood test for a protein called AKR1B10 can help give early warning of liver cancer (hepatocellular carcinoma) in people with cirrhosis. If you have cirrhosis or chronic hepatitis and are between 18 and 75 years old, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis or chronic hepatitis.
- You are between 18 and 75 years old.
- You are willing to take part and sign a consent form.
- You have not been in any other research study in the last 3 months.
- You do not have any severe disease of the heart, brain, lungs, kidneys, or blood system.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This trial tests if a simple blood test can help predict who with cirrhosis might develop liver cancer, so doctors can monitor and treat those patients earlier.
This trial is testing if a protein called AKR1B10 can help detect if liver cancer comes back after surgery. It may offer a simpler way to monitor your health after a successful operation.
This study is testing a new blood test to see if it can help diagnose liver cancer (hepatocellular carcinoma) early in people with liver damage. If you have cirrhosis (scarring of the liver) or hepatitis B, your participation could help improve how we detect liver cancer.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.